ArticleScientific reports2026
Altered serum biomarkers of oxidative stress and antioxidant capacity in primary open-angle glaucoma.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Dual Role of Macroglia in Glaucoma: Deciphering the Contributions of Astrocytes and Müller Cells to Retinal Neurodegeneration and Neuroprotection.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the role of oxidative stress in primary open-angle glaucoma (POAG) by comparing serum levels of ischemia-modified albumin (IMA), malondialdehyde (MDA), and total thiol (TT) between POAG patients and healthy controls. The study included 48 POAG patients and 54 age- and sex-matched healthy controls. Serum concentrations of IMA, MDA, and TT were measured using established assay methods. Statistical analysis revealed significantly higher levels of IMA and MDA and lower levels of TT in POAG patients than controls (p < 0.001). The findings show that patients with POAG tend to have higher oxidative stress levels and a weaker antioxidant defense system. This suggests that POAG patients are exposed to increased oxidative stress and lack sufficient antioxidants to counteract it. The imbalance between oxidants and antioxidants observed in these patients may indicate that oxidative stress plays a potential role in the development of the disease. Further population-based studies are necessary to clarify the causal relationship between these markers and the development or progression of POAG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.